OHB-607-202: A study evaluating the safety and efficacy of an experimental drug for chronic lung disease against normally prescribed care in extremely premature babies (clinicaltrialsregister.eu) - Jun 8, 2026 - P1/2 | N=96 | Active, not recruiting | Sponsor: Ohb Neonatology Limited | Recruiting ➔ Active, not recruiting
Enrollment closed • Bronchopulmonary Dysplasia • Pulmonary Disease • Respiratory Diseases
|